MorphoSys develops and commercializes therapeutic antibodies for the treatment of cancer, inflammatory and autoimmune diseases.
Business Model:
Revenue: $256.2M
Employees: 501-1,000
Address: Semmelweisstr. 7
City: Planegg
State: bavaria
Zip: 82152
Country: DE
MorphoSys develops and commercializes therapeutic antibodies for the treatment of cancer, inflammatory and autoimmune diseases.
Contact Phone:
Contact Email:
Listed Exchange:
FRA
IPO Date:
4/18/2018
Ticker Symbol:
MOR
IPO Price:
$25.04/share
Amount Raised:
$208M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2022 | Human Immunology Biosciences | Series A | 0 |
8/2018 | Adivo | Seed Round | - |
8/2018 | Adivo | Seed Round | - |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2016 | Equity | $123.9M | 4/2018 | IPO | $207.8M | 10/2020 | Post-IPO Debt | $383.8M | 10/2020 | Post-IPO Debt | $381.6M | 1/1992 | Seed Round | 1 | - |
Atlas Venture Atlas Venture |
9/2013 | Post-IPO Equity | $126M | 11/2016 | Post-IPO Equity | $127.6M | 1/1992 | Seed Round | 1 | - |
Atlas Venture Atlas Venture |
---|
Announced Date | Name | Price |
---|---|---|
6/2021 | Constellation Pharmaceuticals | |
5/2015 | Lanthio Pharma | |
10/2010 | Sloning BioTechnology |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|